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BACKGROUND:Drain insertion following chronic subdural hematoma (CSDH) evacuation
improves patient outcomes.
OBJECTIVE: To examine whether this is influenced by variation in drain location,
positioning or duration of placement.
METHODS: We performed a subgroup analysis of a previously reported multicenter,
prospective cohort studyof CSDHpatients performedbetweenMay 2013 and January 2014.
Data were analyzed relating drain location (subdural or subgaleal), position (through a
frontal or parietal burr hole), andduration of insertion, to outcomes in patients aged>16 yr
undergoing burr-hole drainage of primary CSDH. Primary outcomes comprised modified
Rankin scale (mRS) at discharge and symptomatic recurrence requiring redrainage within
60 d.
RESULTS: A total of 577 patients were analyzed. The recurrence rate of 6.7% (12/160) in
the frontal subdural drain group was comparable to 8.8% (30/343) in the parietal subdural
drain group. Only 44/577 (7.6%) patients underwent subgaleal drain insertion. Recurrence
rates were comparable between subdural (7.7%; 41/533) and subgaleal (9.1%; 4/44) groups
(P = .95). We found no significant differences in discharge mRS between these groups.
Recurrence rates were comparable between patients with postoperative drainage for 1 or
2 d, 6.4% and 8.4%, respectively (P= .44). There was no significant difference inmRS scores
between these 2 groups (P= .56).
CONCLUSION: Drain insertion after CSDH drainage is important, but position (subgaleal
or subdural) and duration did not appear to influence recurrence rate or clinical
outcomes. Similarly, drain location did not influence recurrence rate nor outcomes where
both parietal and frontal burr holes were made. Further prospective cohort studies or
randomized controlled trials could provide further clarification.
KEYWORDS: Burr-hole craniostomy, Chronic subdural hematoma, Drains, Outcome, Recurrence
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T he benefit of insertion of a closedsubdural drainage system at the timeof burr-hole drainage of symptomatic
chronic subdural hematoma (CSDH) has
been demonstrated in a randomized controlled
trial1 and 2 meta-analyses.2,3 A multicenter
audit of CSDH treatment in the UK and
ABBREVIATIONS: BHC, burr-hole craniostomy;
CSDH, chronic subdural hematoma;mRS,modified
Rankin scale; TDC, twist-drill craniostomy
Ireland confirmed the benefit of drain insertion
in terms of symptomatic CSDH recurrence
requiring reoperation within 60 d of the index
surgery.4 However, that same study demon-
strated significant variation in the details of
surgical management of symptomatic CSDH
between surgeons.
There is a paucity of literature examining
the precise details of drain insertion and
whether location, position, and duration of
postoperative drainage affect outcomes. The
aim of this study was therefore to determine
the effect of these drain variables on clinical
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outcomes by performing a subgroup analysis of patients in the
national audit.
METHODS
Participants and Study Settings
The study methodology has been described in detail previously.4,5
Briefly, a multicenter, prospective cohort study was conducted to
determine differences in operative and perioperative strategies for
managing patients with CSDH, as well as clinical outcomes. “Study
participants were enrolled at 26 of the 33 UK and Ireland Neuro-
surgical Units (NSUs) between May 2013 and January 2014. Eligi-
bility criteria were age >16 yr, presentation with a primary or recurrent
CSDH confirmed on cranial imaging, and referral to a participating
NSU”.4 Patient demographics, baseline characteristics including medical
conditions and relevant medications, alongside details of pre-, intra-
, and postoperative management were recorded by the local clinical
teams. Symptomatic recurrence was defined as repeat surgical drainage
within 60 d of index admission. “The decision to proceed with
revision surgery was at the discretion of the patient’s consultant neuro-
surgeon, based on clinical symptoms, correlated with imaging”.4 The
modified Rankin scale (mRS) score and destination at discharge from
the NSU, morbidity and mortality, and duration of stay in the NSU
were also recorded. The following mRS was used: 0–no symptoms; 1–
no significant disability (able to carry out all usual activities, despite
some symptoms); 2–slight disability (able to look after own affairs
without assistance, but unable to carry out all previous activities); 3–
moderate disability (requires some help, but able to walk unassisted);
4–moderately severe disability (unable to attend to own bodily needs
without assistance, and unable to walk unassisted); 5–severe disability
(requires constant nursing care and attention, bedridden, incontinent);
6–dead.
The study protocol was approved nationally by the Academic
Committee of the Society of British Neurological Surgeons. Individual
participating NSUs were responsible for controlling their own contrib-
utory data, and also had local governance approvals in place. Individual
patient consent was not required and therefore not sought for this
study.
Patients from the cohort study who were transferred to an NSU and
underwent primary burr-hole craniostomy (BHC) with drain placement
for either unilateral or bilateral CSDH were included in this subgroup
analysis. Patients who had undergone previous drainage of an ipsilateral
CSDHwere excluded. Patients who underwent simultaneous drainage of
bilateral CSDHwere included in our analyses, as previous analyses of this
dataset demonstrated no association between unilateral/bilateral CSDH
and the same outcomes of interest.4 Recurrence occurring on one side in
a patient who underwent drainage of bilateral CSDH was considered as
a single recurrence.
For those patients undergoing drain placement at the time of surgery,
researchers recorded whether this had been placed in the subdural or
subgaleal space (drain location). Drain position (insertion via frontal
or parietal burr hole), and duration of postoperative drainage in days
were recorded. Of the entire cohort, 33 patients had a single burr-
hole operation with drain insertion; these patients were excluded from
the drain-position analysis. However, single-burr-hole operations were
included in the drain location and duration analyses, when relevant
complete data were available.
Statistical Analysis
Chi-squared, Fisher’s exact, parametric and non-parametric tests were
used, when appropriate, to compare baseline clinical characteristics.
These comparisons were made for each subgroup analysis (drain location,
drain position, and duration of drain). We used the Mantel–Haenszel
method to examine potential confounders to the association of interest.
Multiple logistic regression models were used to calculate adjusted odds
ratios. Variables entered into the final multivariate analyses were those
that were shown to influence the association of interest in univariate
analyses, or putative factors for the outcome of interest. Putative factors
entered into the multivariate analyses for recurrence were age, gender,
preoperative GCS, preoperative antiplatelet medication use, and preop-
erative warfarin use. In addition to these factors, dichotomized admission
mRS and bed rest were entered into multivariate analyses for functional
outcome. Functional outcome was the discharge mRS categorized into
favorable (mRS 0-3) and unfavorable (mRS 4-6) outcomes. Likelihood
ratio tests were used to determine the model of choice. Patients with
missing data were excluded if the missing data were relevant to that
particular analysis. Stata version 13.0 (StataCorp LP, College Station,
Texas) was used for all analyses.
RESULTS
Data from 1205 patients were collected in the national audit.
Of these, 577 patients had burr-hole drainage of their CSDH
with drain insertion and were identified for inclusion in our
subgroup analysis; details of their baseline, perioperative, and
operative/postoperative characteristics are detailed in Table 1.
When comparing admission with postoperative mRS, 64.2%
patients showed improvement, 22.8% were the same, and 13%
worsened. A detailed breakdown of the changes inmRS is detailed
in Figure 1. Overall, the rate of symptomatic CSDH recurrence
requiring reoperation within 60 d was 7.8%.
Drain Location and Position
The majority of patients in our analysis underwent subdural
drain insertion (533/577; 92%). The recurrence rate of 7.7%
(41/533) in the subdural drain group was not significantly
different from 9.1% (4/44) in the subgaleal group (P = .95,
Table 2). Placement of the subdural drain via either a frontal or
parietal burr hole (when 2 burr-holes were performed) resulted
in comparable recurrence rates, 6.7% and 8.8%, respectively
(P = .48, Table 2). There were no significant differences in
discharge mRS between the subdural and subgaleal, or between
the frontal and parietal subdural drain groups (Table 2).
Multivariate analyses revealed that when adjusting for the
pre-specified variables that affect recurrence rate and functional
outcome, there appeared to be no correlation between different
drain location/position and outcomes (Tables 3 and 4). A
comparison of complications and mortality for drain location and
position is illustrated in Table 5. In the univariate analyses, there
were no significant differences between the 2 groups except for
new neurological deficit that was seen more commonly when the
drain was placed via a frontal rather than parietal burr hole (4.9%
vs 1.7%, respectively, P = .04). Complications according to the
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TABLE 1. Descriptive Baseline, Perioperative, Operative, and Postoperative Characteristics of 577 Patients Undergoing Burr-Hole Drainage of
CSDHWith Drain Insertion.
Baseline characteristics n (%) Perioperative clinical characteristics n (%) Operative characteristics n(%)
Total number of patients 577 Preoperative platelet transfusion 56 (9.7) Operative laterality
Median age in years (IQR) 78 (98-85) Preoperative vitamin K 91 (15.8) Left 221 (38.3)
Sex Preoperative Fresh Frozen Plasma 13 (2.3) Right 204 (35.4)
Female 183 (31.7) Preoperative GCS (median, IQR) 14 (13-15) Bilateral 138 (23.9)
Male 394 (68.3) GCS 3-8 24 (4.2) Unknown/Missing 14 (2.4)
Comorbidities GCS 9-12 78 (13.5) Anesthesia
Diabetes mellitus 99 (17.2) GCS 13-15 475 (82.3) Local 42 (7.3)
Dementia 64 (11.1) CSDH laterality General 535 (92.7)
Chronic Obstructive Pulmonary Disease 35 (6.1) Left 201 (34.8) Drain location
Cerebrovascular event 95 (16.5) Right 185 (32.1) Subdural 533 (92.4)
Ischemic heart disease 147 (25.5) Bilateral 177 (30.7) Subgaleal 44 (7.6)
Arrhythmia 117 (20.3) Unknown/missing 14 (2.4) Subdural drain placement
Epilepsy 23 (4.0) CSDH density on pre-operative CT scan Frontal 176 (33.0)
CSF shunt 6 (1.0) Hypodense 165 (28.6) Posterior 315 (59.1)
Malignancy 49 (8.5) Isodense 120 (20.8) Unknown 42 (7.9)
Metallic heart valve 11 (1.9) Mixed 292 (50.6) Duration of drain placement
History of head injury within 3 mo 361 (62.6) 1 d 157 (27.2)
Preoperative antithrombotics 245 (42.5) 2 d 392 (67.9)
Antiplatelet medication 137 (23.7) 3+ d 28 (4.9)
Warfarin 108 (18.7) Bed rest
Others 9 (1.6) No specific instructions 215 (37.3)
Admission mRS 1-12 h 37 (6.4)
mRS 0-3 333 (57.7) 12-24 h 231 (40.0)
mRS 4-5 244 (42.3) 24-48 h 85 (14.7)
48+ h 9 (1.6)
duration of drain are shown in Table 6. Self-reported complica-
tions included 1 intracerebral hematoma (0.2%), 3 acute subdural
hematomas (0.6%), and 2 subdural empyemas (0.4%) in the
subdural drain group. None of these complications were reported
in the subgaleal drain group.
Drain Duration
Only 4.9% of patients had drain insertion for at least 3 d, so
were excluded from the subsequent analysis (Table 1). Analysis
of patients with drain insertion for either 1 or 2 d demonstrated
that recurrence rates were comparable between the 2 groups, 6.4%
and 8.4%, respectively (P = .44, Table 2). There was no signif-
icant difference in mRS scores between the 2 groups (P = .56,
Table 2), although on multivariate analysis there appeared to be
a non-significant trend towards worse functional outcome with 2
d of drainage (OR 1.66, P = .09, Table 4).
DISCUSSION
The location, position, and duration of drain insertion
following burr-hole drainage of a chronic subdural hematoma
do not affect symptomatic recurrence requiring repeat surgery, or
functional outcome. This subgroup analysis comprises the largest
study performed on drain position and duration in CSDH. The
symptomatic recurrence rate we observed at 60 d may be under-
estimated if there were even later recurrences; however, previously
published data suggest that recurrence is most likely within this
time period.6 The median time to recurrence in the present study
agrees with that reported previously.7
Where variation in practice does not impact on patient
outcomes, there may be opportunities to simplify care pathways,
reducing costs, and enhancing patient experiences. There are
many operative and perioperative variables in the management
of a patient with CSDH. In our previous multicenter cohort
study, we demonstrated that drain insertion was an important
predictor of outcomes. Other common variations in practice such
as duration of postoperative bed rest and prescription of high-flow
oxygen were not.4
Drain Location
In their randomized controlled trial of drain use, Santarius
and colleagues1 specified drain placement in the subdural space
through either burr hole, kept in a dependent position, and
removed at 48 h. They demonstrated significantly lower recur-
rence rates and improved 6-mo outcomes when compared to no
drain use.1 Follow-up data have also demonstrated better long-
term survival in the drainage group.8 However, the authors did
not indicate the length of drain to be inserted intracranially, and
postoperative imaging was not collected to confirm the position
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FIGURE 1. Change in mRS after burrhole craniostomy and drain placement.
TABLE 2. Outcome Summary Table According to Drain Location, Position, and Duration
Location (n= 577) Subdural position (n= 527) Duration (n= 549)
Subdural
drain (n= 533)
Subgaleal
drain (n= 44) P value
Frontal
(n= 179)
Parietal
(n= 343) P value 1 d (n= 157) 2 d (n= 392) P value
Recurrence .95 .48 .44
No 479 (80.9) 39 (88.6) 160 (89.4) 307 (89.5) 142 (90.5) 352 (89.8)
Yes 41 (7.7) 4 (9.1) 12 (6.7) 30 (8.7) 10 (6.4) 33 (8.4)
Unknown/missing 13 (2.4) 1 (2.3) 7 (3.9) 6 (1.7) 5 (3.2) 7 (1.8)
Discharge mRS .97 .60 .56
mRS 0-3 405 (76.0) 33 (75.0) 139 (77.7) 263 (76.7) 122 (77.7) 297 (75.8)
mRS 4-6 114 (21.4) 10 (22.7) 33 (18.4) 73 (21.3) 30 (19.1) 87 (22.2)
Unknown/missing 14 (2.6) 1 (2.3) 7 (3.9) 7 (2.0) 5 (3.2) 8 (2.0)
of the drain. Similarly, we did not confirm the drain position
radiologically in our cohort and this analysis was dependent on
details recorded in the operative notes.
Gazzeri et al9 and Zumofen et al10 reported retro-
spective medium-sized case series of extracalvarial (subpe-
riosteal/subgaleal) drain insertion following BHC. Neither study
had a subdural drain group for comparison, but the authors
both reported recurrence rates comparable with the published
literature. In a prospective, non-randomized study, Chih
et al11 demonstrated no significant difference in recurrence
rate and functional outcome. A small prospective randomized
study purported no difference in recurrence rates but a better
functional outcome in the subperiosteal drain group; this may
have been confounded by the superior preoperative average mRS
score in the subperiosteal group.12 By contrast, a retrospective
single-center comparative study reported a higher re-operation
rate for symptomatic recurrence in the subgaleal drain group
compared to the subdural drain group, but there was a non-
significant tendency to less-serious complications and lower
1 yr mortality in the subgaleal drain group.13 Similarly, Chih
et al11 observed a non-significant increase in complications in
the subdural drain group.
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TABLE 3. Multiple Logistic Regression Analysis With Adjusted Odds Ratios for Symptomatic Recurrence Requiring Re-operation Within 60 d
According to Drain Location, Position, and Duration in Patients With Complete Data for Analysis.
Location of drain (n= 563) Position of drain (n= 509) Drain duration (n= 537)
OR 95% CI P value OR 95% CI P value OR 95% CI P value
Subdural Ref – – Frontal Ref – – 1 d Ref – –
Subgaleal 0.95 0.31-2.87 .92 Parietal 1.27 0.62-2.60 .51 2 d 1.46 0.65-3.27 .36
Age
Each year increase 1.01 0.98-1.03 .42 1.00 0.98-1.03 .85 1.00 0.98-1.03 .83
Gender
Female Ref – – Ref – – Ref – –
Male 2.85 1.23-6.60 .01 2.56 1.10-5.95 .03 2.49 1.06-5.84 .04
Preoperative GCS
3-12 Ref – – Ref – – Ref – –
13-15 0.42 0.22-0.81 < .01 0.41 0.21-0.80 < .01 0.42 0.21-0.83 .01
Antiplatelet medication 0.63 0.27-1.43 .27 0.64 0.26-1.55 .32 0.66 0.28-1.54 .34
Warfarin 1.35 0.64-2.81 .43 1.51 0.71-3.23 .28 1.50 0.71-3.21 .29
Preoperative
maximal thickness
Each mm increase 1.02 0.99-1.05 .16
Postoperative bed
rest
No specific
instructions
Ref – –
1-12 h 0.31 0.04-2.54 .28
12-24 h 1.46 0.69-3.09 .33
24-48 h 0.96 0.34-2.70 .94
48+ h 2.16 0.21-22.7 .52
OR, Odd’s Ratio; CI, Confidence Interval; Ref, Reference. Bold values are statistical significance in P value.
Perhaps the precise location of drain insertion in relation to
the burr hole is not important. Without a standard definition
of ‘subdural’ and ‘subgaleal’ drain position, it is possible that
the drain positions may not differ that much; some drains
described as being positioned in the subdural space may, in fact,
be inserted a little distance beyond the burr hole, similar to
drains positioned over the burr hole. Proponents of subgaleal
drains argue that by avoiding instrumenting the subdural space,
there should be a reduced risk of intracranial hemorrhage,
brain injury, empyema, and epilepsy. We observed no signif-
icant difference in seizures between subdural and subgaleal drain
groups. However, our results should be interpreted with caution
given the small numbers of subgaleal drains used during the
study period, and likely selection bias, as well as lack of prespec-
ified data collection on intracranial hemorrhage and empyema.
An adequately powered randomized controlled trial of subdural
vs subgaleal drains is needed, one of which is underway in
Switzerland.14
Drain Position
Previous studies have also examined whether there is an
advantage to frontal or parietal drain placement. Two small retro-
spective studies of patients undergoing BHC reported lower
recurrence rate when the drain tip is placed in the frontal position
within the subdural space.15,16 Our results suggest that it does
not matter through which burr hole a drain is placed in terms
of recurrence and functional outcome, although we observed a
higher risk of new neurological deficit when the drain was placed
via the frontal burr hole. It is difficult to ascertain the clinical
significance of this finding because of the small number of events
reported and the reporting of neurological deficit was not part
of our primary outcome, therefore defined broadly and may be
subjected to reporting bias. We are also unable to comment upon
drain direction and ultimate tip position. Several small retro-
spective studies demonstrated no impact of the position of the
intracranial subdural drain on recurrence rates.17-19
Drain Duration
We observed no apparent advantage to drainage for more than
24 h and prompt drain removal may facilitate early mobilization,
which, in turn, could reduce morbidity and improve functional
outcomes. Previous studies examining the impact of duration
of postoperative drainage on CSDH recurrence and functional
outcomes are contradictory. Kale et al20 retrospectively compared
recurrence rates after BHC in those drained for 2 to 4 d vs 5
to 7 d. They reported a significantly lower recurrence rate in
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TABLE4. Multiple LogisticRegressionAnalysisWithAdjustedOddsRatios forUnfavorableOutcome (mRS4-6) atDischarge inPatientsAccording
to Drain Location, Position, and DurationWith Complete Data for Analysis
Location of drain (n= 562) Position of drain (n= 508) Drain duration (n= 530)
OR 95% CI P value OR 95% CI P value OR 95% CI P value
Subdural Ref – – Frontal Ref – – 1 d Ref – –
Subgaleal 1.11 0.45-2.74 .83 Parietal 0.88 0.51-1.55 .67 2 d 1.66 0.93-2.94 .09
Age
Each year increase 1.07 1.05-1.10 < .01 1.09 1.06-1.12 < .01 1.07 1.04-1.10 < .01
Gender
Female Ref – – Ref – – Ref – –
Male 0.71 0.44-1.16 .17 0.69 0.41-1.17 .17 0.71 0.43-1.17 .18
Admission mRS
mRS 0-3 Ref – – Ref – – Ref – –
mRS 4-5 3.77 2.24-6.34 < .01 3.71 2.13-6.46 < .01 0.41 0.24-0.69 < .01
Pre-operative GCS 0.92 0.53-1.61 .78
3-12 Ref – – Ref – – 0.71 0.37-1.35 .29
13-15 0.42 0.25-0.69 < .01 0.46 0.27-0.79 < .01
Antiplatelet medication 1.11 0.65-1.87 .71 1.07 0.60-1.90 .82 Ref – –
Warfarin 0.80 0.44-1.48 .48 0.85 0.45-1.62 .63 3.80 2.24-6.46 < .01
Bed rest
No specific instructions Ref – – Ref – – Ref – –
1-12 h 1.36 0.46-3.97 .58 1.29 0.36-4.61 .69 1.51 0.51-4.46 .45
12-24 h 1.58 0.92-2.72 .10 1.63 0.90-2.95 .11 1.91 1.07-3.40 .03
24-48 h 1.87 0.94-3.70 .07 2.13 0.99-4.59 .05 1.88 0.92-3.84 .08
48+ h 8.30 1.00-688 .05 8.94 1.05-76.2 .05 ∗ – – –
OR, Odd’s Ratio; CI, Confidence Interval; Ref, Reference. Bold values are statistical significance in P value.
TABLE 5. Postoperative Complications in Patients With Differing Drain Location and Position
Drain location Drain position
Complication location Subdural Subgaleal P-value Frontal Parietal P-value
Surgical site infection 3 (0.6) 0 (0) .62 1 (0.6) 2 (0.6) .96
Seizures 8 (1.5) 2 (4.6) .14 2 (1.1) 7 (2.0) .43
New deficit 17 (3.2) 0 (0) .23 9 (4.9) 6 (1.7) .04
Respiratory infection 43 (8.1) 3 (6.8) .77 13 (7.1) 28 (8.1) .67
New arrhythmia 8 (1.5) 0 (0) .41 2 (1.1) 6 (1.7) .56
Venous thromboembolic event 2 (0.4) 0 (0) .68 1 (0.6) 1 (0.3) .65
Myocardial infarction 2 (0.4) 1 (2.3) .09 0 (0) 2 (0.6) .30
Cerebrovascular event 7 (1.3) 0 (0) .44 4 (2.2) 3 (0.9) .21
Death 9 (1.7) 0 (0) .39 2 (1.1) 6 (1.7) .56
Bold values are statistical significance in P-value.
the 5 to 7 d group (3.3% vs 15.6%), although the difference
in actual reoperation rate between groups was much less stark
(5% vs 2%). Yu et al21 reported significantly different recurrence
rates in their retrospective series of 97 patients undergoing BHC
(16.3% for patients drained<3 d vs 1.3% in those drained≥3d),
although presenting GCS scores were not recorded and may
have differed between 2 groups. A randomized controlled trial
comparing 48 h vs 96 h of postoperative drainage after twist-drill
craniostomy (TDC) demonstrated no difference in recurrence
rates, but increased mortality and complications and in the 96 h
group.22 Sindou et al23 also performed a small randomized study
comparing the same drainage durations in TDC and reported
similar results. Jeong Si et al16 found no difference in recurrence
rate when comparing <2 d and ≥2 d in BHC. Given the size
and design of these studies, it is difficult to ignore the findings of
the high-quality drain study from Santarius and colleagues1 that
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TABLE 6. Postoperative Complications in Patients With Differing
Drain Duration
1 d (n= 157) 2 d (n= 392) P-value
Surgical site infection 3 (1.9) 0 (0) < .01
Seizures 2 (1.3) 7 (1.8) .67
New deficit 3 (1.9) 13 (3.3) .38
Respiratory infection 14 (8.9) 30 (7.7) .62
New arrhythmia 0 (0) 7 (1.8) .09
Venous thromboembolic event 0 (0) 2 (0.5) .37
Myocardial infarction 0 (0) 3 (0.8) .28
Cerebrovascular event 2 (1.3) 5 (1.3) 1.00
Death 5 (3.2) 4 (1.0) .07
utilized a 48 h drainage period.8 The question of drain duration
merits further study.
CONCLUSION
Recurrence rate and functional outcome after drainage of
primary CSDH by BHC does not appear to be affected by
drain location, position, or duration of drainage. Choice of
drain position and duration will be guided by surgeon preference
and intraoperative findings, but variation in practice may not
influence outcomes. Well-designed and adequately powered
randomized controlled trials will help interrogate questions of
drain position, location, and duration further.
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T he authors have evaluated the formidable question as to whetherdrain location, position, and duration impact outcomes in the
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C hronic subdural hematoma (CSDH) is an increasingly commondisorder in neurosurgical practice. The present article is part of
a multicenter, prospective cohort study of 577 CSDH patient treated
in the UK. Subgaleal drains were uncommonly used and the study
is thus underpowered to answer whether drain location (subgaleal or
subdural) is a factor influencing recurrence and/or complication rates.
Drain duration, 1 or 2 days, did not influence recurrence rates. This
is an important finding, suggesting that earlier drain removal could
be considered allowing faster mobilization of the patient. This well-
written study demonstrates the benefits of nation-wide, multicenter
surveys of the treatment of common neurosurgical diseases. The provided
results are relevant for the neurosurgeon involved in the care of CSDH
patients.
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